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Materials and methods
All reagents were commercially available and used as supplied without further purification. Solvents were either employed as purchased or dried according to procedures described in the literature. M, S1 
PTPE,
S2
P5, S3 and P5-PEG-Biotin S3 were prepared according to literature procedures. 1 H NMR and 13 C NMR spectra were recorded on a Bruker Avance-400 spectrometry. The 2D NOESY NMR spectrum was collected on a Bruker Avance DMX-500 spectrometer with internal standard TMS. Low-resolution electrospray ionization (LRESI) mass spectra were obtained on a Bruker Esquire 3000 plus mass spectrometer (Bruker-Franzen Analytik GmbH Bremen, Germany) equipped with an ESI interface and an ion trap analyzer. HRMS were obtained on a WATERS GCT Premier mass spectrometer. The melting points were collected on a SHPSIC WRS-2 automatic melting point apparatus. The fluorescence experiments were conducted on a RF-5301 spectrofluorophotometer (Shimadzu Corporation, Japan).
Transmission electron microscopy (TEM) investigations were carried out on a HT-7700 instrument.
Scanning electron microscopy (SEM) investigations were carried out on a Multimode 8 instrument.
Molecular weights and distributions were determined by gel permeation chromatography (GPC) with a Waters 1515 pump and Waters 1515 differential refractive index detector (set at 30 °C).
TEM and DLS Studies. The nanostructures of the nanoparticles were revealed using TEM. TEM samples were prepared by drop-coating a solution onto a carbon-coated copper grid. TEM experiments were performed on a HT-7700 instrument. The corresponding solution was left to stand overnight and the insoluble precipitate was eliminated by using a microporous membrane before DLS tests. Dynamic light scattering (DLS) measurements were carried out using a 200 mW polarized laser source Nd:YAG (λ = 532 nm). The polarized scattered light was collected at 90° in a self-beating mode with a Hamamatsu R942/02 photomultiplier. The signals were sent to a Malvern 4700 submicrometer particle analyzer system. DOX Loading and Release. PTPE (16.0 mg), P5-PEG-Biotin (71.7 mg), and DOX·HCl (50 mg) were dissolved in the mixture of water (10 mL) and THF (10 mL) in the presence of triethylamine (TEA). After stirring in the dark for 24 h, THF was evaporated by N 2 flow. The DOX-loaded SNPs were purified by dialysis (molecular weight cut-off 3000) in distilled water until the water outside the dialysis bag The DOX release from the DOX-loaded SNPs was studied in different pH buffer solutions. A dialysis bag with 2 mL of the DOX-loaded SNPs solution was added into the corresponding release medium (18 mL) at 37 °C. At specified time intervals, the concentration of DOX was determined by UVVis spectrophotometry.
For reduction-triggered release studies, the DOX-loaded SNPs were dissolved in 2 mL of a phosphate buffer solution in the absence or presence of Na 2 S 2 O 4 sealed in a dialysis bag with a molecular weight cut-off of 3 kDa. The dialysis apparatus was agitated on an orbital shaker at 100 rpm at 37 °C. At designated time intervals, 1 mL of medium was taken out from the 25 mL solution out of the dialysis bag for UV detection and was then put back to the original system. The DOX concentration in the solution was calculated based on the standard curve calibrated with a DOX solution with a known concentration. After 4 h of incubation at 37 °C, the MTT solution was removed, and the insoluble formazan crystals that formed were dissolved in 100 μL of dimethylsulfoxide (DMSO). The absorbance of the formazan product was measured at 570 nm using a spectrophotometer (Bio-Rad Model 680). Untreated cells in media were used as a control. All experiments were carried out with five replicates.
In Vitro Cell Accumulation of DOX Determined by Flow Cytometry. Cellular uptake of the DOXloaded SNPs was measured by flow cytometry. HeLa and HEK293 cells were seeded at a density of 3.00 S4 × 10 5 cells/well in 12-well cell culture plates. The cells were left to grow for 24 h in DMEM media containing 10% FBS at 37 C in 5% CO 2 atmosphere. After 24 h, the DOX-loaded SNPs (the concentration of DOX was 5.00 μM) were added to the wells and the cells were incubated for 30 min, 1 h, 2 h, and 4 h, respectively. Following incubation, cells were rinsed twice with PBS to remove residual DOX-loaded SNPs. Cells were harvested by trypsinization and resuspended in 500 μL of PBS for flow cytometry analysis using the FACS Calibur flow cytometer (BD Facsealibur). Data shown in this paper are the mean fluorescent signal for 1.00 × 10 4 cells. Cells without any treatment were used as a control.
Data was analyzed using the FlowJo software.
In Vitro Cell Accumulation Determined by Confocal Laser Scanning Microscopy. HeLa and HEK293 cells were treated with DOX-loaded SNPs (the concentration of DOX was 5.00 μM) in the culture medium at 37 °C for 0.5 h, 2 h, and 4 h, respectively. The cells were washed three times with PBS, fixed with fresh 4.0% formaldehyde at room temperature for 15 min, and washed with PBS for two times.
The images were taken using a LSM-510 confocal laser scanning microscope (Zeiss, Germany) (100 × oil objective, 405/488 nm excitation). 
Pharmacokinetics and Biodistribution.
For pharmacokinetic studies, the mice were randomly divided into two groups (n = 3). The aqueous solutions of free DOX·HCl and the DOX-loaded SNPs were i.v.
injected at a dose of 5 mg/kg. The blood samples (0.2 mL) were taken from retro-orbital sinus at desired time after injection. The plasma was obtained by centrifugation at 10000 rpm for 15 min to isolate the plasma, and the amount of DOX in the plasma was assayed by HPLC. In Vivo Antitumor Efficacy Evaluation. The nude mice were divided into three treatment groups randomly (n = 7), when the mean tumor volume reached about 100 mm 3 and this day was set as day 0.
Mice were administered intravenously with PBS, free DOX, and the DOX-loaded SNPs at dose of 5 mg DOX/kg body weight every 3 days for four times. Tumor volume and body weight were measured every 3 days. The tumor inhibition study was stopped on the 21 st day and the survival rate study was stopped on the 30 th day.
Tissue Immunohistological Evaluation. In the histological assay, the heart, liver, spleen, lung, kidney and tumor tissues were fixed in 4% paraformaldehyde for 24 h. The specimens were dehydrated in graded ethanol, embedded in paraffin, and cut into 5 mm thick sections. The fixed sections were deparaffinized and hydrated according to a standard protocol and stained with hematoxylin and eosin (H&E) for microscopic observation. Apoptosis of the tumor cells in the mice after treatments was determined by the TUNEL method according to the manufacturer's instructions. The cell proliferations in tumor tissues were measured by anti-Ki67 monoclonal antibody according to the manufacturer's instructions.
Statistical analysis.
Data are presented as the mean ± standard deviation (SD). Statistical analysis of data was performed with one-way analysis of variance (ANOVA). The level of significance was defined at *p < 0.05, **p < 0.01.
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2. Synthesis of PTPE Scheme S1. Synthetic route to PTPE.
Fig. S1
1 H NMR spectrum (400 MHz, chloroform-d, room temperature) of 4. 
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Investigations of the hostguest interactions
Critical aggregation concentration (CAC) determination
Some parameters such as the conductivity, osmotic pressure, fluorescence intensity and surface tension of the solution change sharply around the critical aggregation concentration. Here, the dependence of the fluorescence intensity at 471 nm vs. solution concentration was used to determine the critical aggregation concentration (CAC).
When the concentration of PTPE (or P5-PEG-BiotinPTPE) is lower than the CAC value, the fluorescence intensity increased slowly. However, fluorescence intensity increased sharply when the concentration was higher than the CAC value due to the AIE effect arising from the self-assembly of P5-PEG-BiotinPTPE. Therefore, the junction of the fluorescence intensity at 471 nm-concentration plot represents the CAC value. S17
In vivo investigations
